Fortis Healthcare Limited
Fortis Healthcare announced that the Tokyo District Court has concluded preparatory and oral proceedings for the material litigation between Northern TK Venture Pte Ltd and Daiichi Sankyo. The judgment for this case is scheduled to be announced on September 10, 2026.
Apr 29 2026 13:04:00
Fortis Healthcare Ltd - 532843 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 ('SEBI Listing Regulations') Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan.
Fortis Healthcare announced the conclusion of preparatory and oral proceedings for its material litigation with Northern TK Venture against Daiichi Sankyo in the Tokyo District Court. The judgment for this significant case is now scheduled to be announced on September 10, 2026.
Apr 29 2026 13:04:00
Stocks to buy in 2026 for long term: PNB Housing, Fortis Healthcare among 5 stocks that could give 10-20% return
Brokerages have identified Fortis Healthcare among five stocks with potential for 10-20% returns for long-term investors in 2026, citing selective optimism across healthcare and other key sectors despite market volatility.
Apr 27 2026 07:04:00
Fortis Healthcare Limited
Fortis Healthcare will host an investor/analyst non-deal roadshow on April 27-28, 2026, in Mumbai. The meeting will involve one-on-one and group discussions on the company's general business update and industry outlook.
Apr 22 2026 17:04:00
Fortis Healthcare Limited
Fortis Healthcare will host an investor/analyst non-deal roadshow on April 27-28, 2026, in Mumbai. The meeting will involve one-on-one and group discussions on the company's general business update and industry outlook.
Apr 22 2026 17:04:00
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fortis Healthcare will host investor and analyst meetings on April 27-28, 2026. These meetings in Mumbai will cover general business updates and industry discussions.
Apr 22 2026 16:04:00
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fortis Healthcare will host investor and analyst meetings on April 27-28, 2026. These meetings in Mumbai will cover general business updates and industry discussions.
Apr 22 2026 16:04:00
Fortis Healthcare Limited
Fortis Healthcare disclosed details of non-convertible securities and commercial paper for FY26 as per SEBI Master Circular. This includes listing data for three issues totaling ₹1550 crores and current Stable AA+ credit ratings from CRISIL.
Apr 10 2026 12:04:00
Fortis Healthcare Ltd - 532843 - Disclosure Under Chapter XIV - Centralized Database For Corporate Bonds/ Debentures Of SEBI Master Circular Dated October 15, 2025.
Fortis Healthcare disclosed comprehensive details of non-convertible securities and commercial paper totaling ₹1550 crore for the financial year ended March 31, 2026. This filing ensures compliance with the SEBI Master Circular, enhancing transparency on its debt instruments and their credit ratings.
Apr 10 2026 12:04:00
Fortis Healthcare Limited
Fortis Healthcare reported details of ₹1,550 crore debt securities issued through private placement. These securities bear a 7.7648% annual coupon for the first year, with an issuance date of December 19, 2024, and maturity in December 2029.
Apr 08 2026 18:04:00
Read More